Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

Clinical trial NCT00570674 · TERMINATED

Trial details

NCT number: NCT00570674
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck Basaloid Squamous Cell Carcinoma Undifferentiated Carcinoma Adenosquamous Cell Carcinoma

Start date: 2007-11-01
Primary completion: 2013-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.